TSX closed
Loading markets…

Advertisement

Stocks

Will Cipher Pharmaceuticals Inc (CPH) Beat Estimates Again in Its Next Earnings Report?

By Wealth Awesome -

Follow live quotes and coverage.

Stocks & ETFs:CPH.TO

Follow CPH

Photos provided by Pexels

Cipher Pharmaceuticals is about to release its latest earnings report, and investors are curious to see if the company can keep up its streak of positive surprises.

Recent earnings trend

Advertisement

Cipher Pharmaceuticals Inc

CPH.TO

Full stock page →

CPH.TO

Cipher Pharmaceuticals Inc

Source:WealthAwesomeWealthAwesome
$3.75 (-20.51%)
120 day period
$13.68$16.71$19.74Apr 1Jun 26Sep 22

Market cap

$369.28M

P/E

9.3x

52W high

$20.56

52W low

$12.48

1W change

-0.21%

Beta

0.40

Analyst Price Targets

Based on analyst covering CPH · as of Sep 23, 2026

📈

Wall Street analysts forecast CPH stock price to rise 33.9% over the next 12 months.

Consensus

Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$19.45

+33.9% Upside

Previously C$19.95 on Sep 17, 2026

Current Price

C$14.53

Last close

Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on CPH's historical volatility

HistoricalForecast68%95%
C$4.86C$9.96C$15.05C$20.15C$25.24C$30.34TodayMay 14Jul 20Sep 22Nov 4Dec 18Jan 30

30-Day Vol

74.1%

Annualized

90-Day Vol

46.3%

Annualized

Trend (90d)

-50.0%

Annualized drift

90d Mean

C$12.15

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$13.69C$10.60C$17.68
60 trading daysC$12.90C$8.99C$18.51
90 trading daysC$12.15C$7.81C$18.92

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Advertisement

Analyst coverage: 2 analyst(s) cover this name; upcoming EPS consensus is available.

Beat estimates in 4 of the last 4 comparable quarter(s).

Fiscal periodReport dateActual EPSEstimateSurprise
2026-06-302026-08-110.2600
2026-03-312026-05-070.33000.2200+50.0%
2025-12-312026-03-120.69000.2100+228.6%
2025-09-302025-11-060.30000.1700+76.5%
2025-06-302025-08-070.30000.2200+36.4%
2025-03-312025-05-080.14000.1500-6.7%
0.00000.34500.6900 24-0624-0924-1225-0325-0625-0925-1226-03 Estimate Actual (≥0) Actual (<0) Wealth Awesome

On August 11, 2026, Cipher Pharmaceuticals Inc (CPH.TO) will announce its earnings for the fiscal period ending June 30, 2026. With a solid history of exceeding earnings estimates, this upcoming report is generating significant interest among investors. This preview will look into the expected performance metrics and the broader business context surrounding Cipher Pharmaceuticals.

Investor takeaway: Cipher Pharmaceuticals has consistently shown strong performance. Although analysts have lowered their EPS expectations for the upcoming report, the company's track record suggests it could still deliver a positive surprise.

Upcoming EPS Estimate: $0.26

Cipher Pharmaceuticals has beaten earnings estimates in the last four quarters, with an average surprise of 73.75%, demonstrating its ability to consistently outperform expectations.

Advertisement

Bull case

Cipher's recent earnings history shows a clear pattern of exceeding estimates significantly, with a surprise of over 50% in the last reported quarter. This trend, along with a strong profit margin of 60.60%, highlights the company's operational strength and potential for continued growth.

Bear case

Despite Cipher's impressive past performance, analysts have lowered their EPS consensus from $0.30 to $0.24. If the company fails to meet even this reduced expectation, it could raise concerns about its growth trajectory and market position.

Earnings Expectations

Historical Performance

Analyst Sentiment


Advertisement

Wealth Awesome
Written by

Wealth Awesome

Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.

View Full Profile →

✅ Reviewed by Certified Financial Professionals

This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.

Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.

📊 Data AccuracyVerified sources
🇨🇦 Canadian FocusLocal expertise
🔍 Fact-CheckedEditorial review

⚠️ Professional Disclaimer

This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.

Published: August 10, 2026
Last Updated: August 10, 2026

Sponsored links

Advertisement